期刊文献+

芪术颗粒对糖尿病肾病气阴两虚、痰浊阻络证大鼠早期蛋白尿抑制作用 被引量:7

Inhibitory Effects of Qi-Zhu Granules on Early Proteinuria in Diabetic Nephropathy Rats with Syndrome of Qi-yin Deficiency and Phlegm Blocking Collaterals
下载PDF
导出
摘要 目的:观察芪术颗粒对糖尿病肾病气阴两虚、痰浊阻络证大鼠早期蛋白尿抑制作用。方法:44只大鼠随机分为空白组、模型组、黄葵胶囊组和芪术颗粒组。采用单侧肾结扎合并高热量胆固醇饮食同时复合低剂量链脲佐菌素腹腔注射的方法,建立糖尿病肾病气阴两虚、痰浊阻络证大鼠模型,连续给药8周,观察第4周后大鼠蛋白尿、尿肌酐以及实验结束后血糖、血脂、肝功能和肾脏病理结构的变化。结果:与模型组比较,芪术颗粒可以明显抑制糖尿病肾病早期蛋白尿,促进肌酐排泄,同时调节血脂代谢,保护肝功能,改善肾脏组织病理学变化。结论:芪术颗粒对糖尿病肾病气阴两虚、痰浊阻络证大鼠早期蛋白尿具有独立抑制作用,并不依赖于降血糖作用,体现了中药复方功效与病证的对应关系。 ThisstudywasaimedtoobservetheinhibitoryeffectsofQi-Zhu (QZ)granulesonearlyproteinuria in diabetic nephropathy rats with syndrome of qi-yin deficiency and phlegm blocking collaterals. A total of 44 rats were randomly divided into the blank group, model group, Huang-Kui capsule group, QZ granules group. The rat model of diabetic nephropathy with syndrome of qi-yin deficiency and phlegm blocking collaterals was induced by the combination of unilateral renal artery ligation, diet of high-calorie and high cholesterol, and intraperitoneal injection of low-dose streptozotocin. The medication was given for 8 weeks. The concentrations of protein and creatinine in urine were observed on the 4th week. The blood glucose, blood lipids, liver function and renal pathological changes were observed at the end of the experiment. The results showed that compared with the model group, QZ granules can obvious suppress early proteinuria in diabetic nephropathy, promote creatinine excretion, regulate blood lipid metabolism, protect liver function and improve renal pathological changes. It was concluded that QZ granules had independent inhibition effect on early proteinuria in diabetic nephropathy rats with syndrome of qi-yin deficiency and phlegm blocking collaterals. The effect was independent of lowing blood glucose. It represented the corresponding relation between the syndrome and efficacy in Chinese herb compounds.
出处 《世界科学技术-中医药现代化》 2015年第7期1392-1397,共6页 Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology
基金 科学技术部国家科技重大专项"重大新药创制"项目(2012ZX09103201-040):中药候选药物研究 负责人:洪晓华 科学技术部国家科技重大专项"重大新药创制"项目(2012ZX09301002-004-002):治疗缺血性心脏病及血管病变药物药效学评价体系建立 负责人:侯金才 科学技术部国家重点基础研究发展计划"973计划"项目(2015CB554405):气血相关理论的生物学基础研究 负责人:刘建勋
关键词 芪术颗粒 糖尿病肾病 早期蛋白尿 证候 Qi-Zhu granules diabetic nephropathy early proteinuria syndrome
  • 相关文献

参考文献12

二级参考文献94

共引文献411

同被引文献177

引证文献7

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部